Displaying drugs 1701 - 1725 of 3223 in total
N-9-Methoxynonyldeoxynojirimycin
Investigational
Matched Synonyms: … 3,4,5-piperidinetriol, 2-(hydroxymethyl)-1-(9-methoxynonyl)-, (2r,3r,4r,5s)- …
Matched Name: … N-9-Methoxynonyldeoxynojirimycin …
Matched Iupac: … (2R,3R,4R,5S)-2-(hydroxymethyl)-1-(9-methoxynonyl)piperidine-3,4,5-triol …
Matched Salts name: … N-9-Methoxynonyldeoxynojirimycin hydrochloride …
Matched Name: … N-9-Methoxynonyldeoxynojirimycin …
Matched Iupac: … (2R,3R,4R,5S)-2-(hydroxymethyl)-1-(9-methoxynonyl)piperidine-3,4,5-triol …
Matched Salts name: … N-9-Methoxynonyldeoxynojirimycin hydrochloride …
WU-NK-101
WU-NK-101 is an allogeneic CD3-depleted, CD56-enriched activated natural killer-cell product
Investigational
Matched Name: … WU-NK-101 …
Matched Description: … WU-NK-101 is an allogeneic CD3-depleted, CD56-enriched activated natural killer-cell product …
Matched Description: … WU-NK-101 is an allogeneic CD3-depleted, CD56-enriched activated natural killer-cell product …
SIS-101-ADO
SIS-101-ADO is a siRNA therapeutic under investigation for the treatment of Autosomal Dominant Osteopetrosis Type 2 (ADO2).
Investigational
Matched Name: … SIS-101-ADO …
Matched Description: … SIS-101-ADO is a siRNA therapeutic under investigation for the treatment of Autosomal Dominant Osteopetrosis …
Matched Description: … SIS-101-ADO is a siRNA therapeutic under investigation for the treatment of Autosomal Dominant Osteopetrosis …
P-BCMA-101
P-BCMA-101 is an autologous CAR-T therapy developed using Poseida’s piggyBac platform technology.
Investigational
Matched Name: … P-BCMA-101 …
Matched Description: … P-BCMA-101 is an autologous CAR-T therapy developed using Poseida’s piggyBac platform technology. …
Matched Description: … P-BCMA-101 is an autologous CAR-T therapy developed using Poseida’s piggyBac platform technology. …
9(S)-HODE
Experimental
Matched Synonyms: … (9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid …
Matched Name: … 9(S)-HODE …
Matched Iupac: … (9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid …
Matched Name: … 9(S)-HODE …
Matched Iupac: … (9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid …
S-9-(2-hydroxypropyl)adenine
Experimental
Matched Synonyms: … 9-Hydroxypropyladenine, S-Isomer …
Matched Name: … S-9-(2-hydroxypropyl)adenine …
Matched Iupac: … (2S)-1-(6-amino-9H-purin-9-yl)propan-2-ol …
Matched Name: … S-9-(2-hydroxypropyl)adenine …
Matched Iupac: … (2S)-1-(6-amino-9H-purin-9-yl)propan-2-ol …
R-9-(2-hydroxypropyl)adenine
Experimental
Matched Synonyms: … 9-Hydroxypropyladenine, R-Isomer …
Matched Name: … R-9-(2-hydroxypropyl)adenine …
Matched Iupac: … (2R)-1-(6-amino-9H-purin-9-yl)propan-2-ol …
Matched Name: … R-9-(2-hydroxypropyl)adenine …
Matched Iupac: … (2R)-1-(6-amino-9H-purin-9-yl)propan-2-ol …
AN-9
Pivaloyloxymethyl butyrate (AN-9), an acyloxyalkyl ester prodrug of butyric acid (BA), exhibited low toxicity and significant anticancer activity in vitro and in vivo. It shows greater potency than BA at inducing malignant cell differentiation and tumor growth inhibition and has demonstrated more favorable toxicological, pharmacological, and pharmaceutical properties than BA...
Investigational
Matched Name: … AN-9 …
Matched Description: … Pivaloyloxymethyl butyrate (AN-9), an acyloxyalkyl ester prodrug of butyric acid (BA), exhibited low …
Matched Description: … Pivaloyloxymethyl butyrate (AN-9), an acyloxyalkyl ester prodrug of butyric acid (BA), exhibited low …
9-Methylguanine
Experimental
Matched Name: … 9-Methylguanine …
Matched Iupac: … 2-amino-9-methyl-6,9-dihydro-1H-purin-6-one …
Matched Iupac: … 2-amino-9-methyl-6,9-dihydro-1H-purin-6-one …
9-aminocamptothecin
Aminocamptothecin has been used in trials studying the treatment of Lymphoma, Gastric Cancer, Ovarian Cancer, Esophageal Cancer, and Ovarian Neoplasms, among others.
Investigational
Matched Name: … 9-aminocamptothecin …
Matched Iupac: … hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20 …
Matched Iupac: … hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20 …
Zn(Ii)-(20-Oxo-Protoporphyrin Ix)
Experimental
Matched Name: … Zn(Ii)-(20-Oxo-Protoporphyrin Ix) …
Matched Iupac: … 3-[20-(2-carboxyethyl)-9,14-diethenyl-17-hydroxy-5,10,15,19-tetramethyl-2,22,23,25-tetraaza-1-zincaoctacyclo …
Matched Iupac: … 3-[20-(2-carboxyethyl)-9,14-diethenyl-17-hydroxy-5,10,15,19-tetramethyl-2,22,23,25-tetraaza-1-zincaoctacyclo …
3-(10-methyl-9-anthryl)propanoic acid
Experimental
Matched Synonyms: … 3-(10-methyl-9-anthryl)propionic acid ... 3-(10-METHYL-ANTHRACEN-9-YL)-PROPIONIC ACID …
Matched Name: … 3-(10-methyl-9-anthryl)propanoic acid …
Matched Iupac: … 3-(10-methylanthracen-9-yl)propanoic acid …
Matched Name: … 3-(10-methyl-9-anthryl)propanoic acid …
Matched Iupac: … 3-(10-methylanthracen-9-yl)propanoic acid …
9-Methyl Uric Acid
Experimental
Matched Name: … 9-Methyl Uric Acid …
Matched Iupac: … 9-methyl-2,3,6,7,8,9-hexahydro-1H-purine-2,6,8-trione …
Matched Iupac: … 9-methyl-2,3,6,7,8,9-hexahydro-1H-purine-2,6,8-trione …
9-N-Phenylmethylamino-Tacrine
Experimental
Matched Name: … 9-N-Phenylmethylamino-Tacrine …
Matched Iupac: … N-benzyl-1,2,3,4-tetrahydroacridin-9-amine …
Matched Iupac: … N-benzyl-1,2,3,4-tetrahydroacridin-9-amine …
9-amino-n-[3-(dimethylamino)propyl]acridine-4-carboxamide
9-amino-n-[3-(dimethylamino)propyl]acridine-4-carboxamide is an inactive derivative of the antitumour agents N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA) and 9-amino-DACA.
Experimental
Matched Synonyms: … 9-amino-N-(3-dimethylaminopropyl)acridine-4-carboxamide …
Matched Name: … 9-amino-n-[3-(dimethylamino)propyl]acridine-4-carboxamide …
Matched Iupac: … 9-amino-N-[3-(dimethylamino)propyl]acridine-4-carboxamide …
Matched Description: … agents N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA) and 9-amino-DACA. ... 9-amino-n-[3-(dimethylamino)propyl]acridine-4-carboxamide is an inactive derivative of the antitumour …
Matched Name: … 9-amino-n-[3-(dimethylamino)propyl]acridine-4-carboxamide …
Matched Iupac: … 9-amino-N-[3-(dimethylamino)propyl]acridine-4-carboxamide …
Matched Description: … agents N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA) and 9-amino-DACA. ... 9-amino-n-[3-(dimethylamino)propyl]acridine-4-carboxamide is an inactive derivative of the antitumour …
2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid
Experimental
Matched Name: … 2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid …
Matched Iupac: … (2S,3S,6R,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldecanoic acid …
Matched Iupac: … (2S,3S,6R,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldecanoic acid …
6-fluoro-9-methyl-9H-pyrido(3,4-B)-indole
Investigational
Matched Synonyms: … 6-fluoro-9-methyl-9H-pyrido[3,4-b]-indole …
Matched Name: … 6-fluoro-9-methyl-9H-pyrido(3,4-B)-indole …
Matched Iupac: … 6-fluoro-9-methyl-9H-pyrido[3,4-b]indole …
Matched Name: … 6-fluoro-9-methyl-9H-pyrido(3,4-B)-indole …
Matched Iupac: … 6-fluoro-9-methyl-9H-pyrido[3,4-b]indole …
9-(4-hydroxybutyl)-N2-phenylguanine
9-(4-hydroxybutyl)-N2-phenylguanine is a solid. This compound belongs to the hypoxanthines. These are compounds containing the purine derivative 1H-purin-6(9H)-one. 9-(4-hydroxybutyl)-n2-phenylguanine is known to target thymidine kinase.
Experimental
Matched Name: … 9-(4-hydroxybutyl)-N2-phenylguanine …
Matched Iupac: … 9-(4-hydroxybutyl)-2-(phenylamino)-6,9-dihydro-1H-purin-6-one …
Matched Description: … 9-(4-hydroxybutyl)-N2-phenylguanine is a solid. This compound belongs to the hypoxanthines. ... These are compounds containing the purine derivative 1H-purin-6(9H)-one. 9-(4-hydroxybutyl)-n2-phenylguanine …
Matched Iupac: … 9-(4-hydroxybutyl)-2-(phenylamino)-6,9-dihydro-1H-purin-6-one …
Matched Description: … 9-(4-hydroxybutyl)-N2-phenylguanine is a solid. This compound belongs to the hypoxanthines. ... These are compounds containing the purine derivative 1H-purin-6(9H)-one. 9-(4-hydroxybutyl)-n2-phenylguanine …
Hg9a-9, Nonanoyl-N-Hydroxyethylglucamide
Experimental
Matched Name: … Hg9a-9, Nonanoyl-N-Hydroxyethylglucamide …
Displaying drugs 1701 - 1725 of 3223 in total